FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 8015285 · Received October 29, 2018

Report

Report Number
1823260-2018-03891
Event Type
Malfunction
Date Received
October 29, 2018
Date of Event
July 5, 2018
Report Date
October 29, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
1823260-08/30/18-005-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER STATED THAT A PATIENT RECEIVED ERRONEOUS RESULTS WHEN TESTING WITH THE PATIENT'S COAGUCHEK INRANGE METER SERIAL NUMBER (B)(4). THE TIME FRAME BETWEEN ALL MEASUREMENTS IS UNKNOWN. THIS MEDWATCH WILL APPLY TO TEST STRIP LOT NUMBER 29778816. PLEASE REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO TEST STRIP LOT NUMBER 244033. A SAMPLE FROM THE PATIENT WAS TESTED ON THE METER USING TEST STRIP LOT NUMBER 29778816, RESULTING WITH A VALUE OF 4.5 INR. AT AN UNKNOWN TIME, A SAMPLE FROM THE PATIENT WAS TESTED IN THE LABORATORY USING AN UNKNOWN METHOD, RESULTING AS 3.55 INR. AT A LATER UNKNOWN TIME, A SAMPLE FROM THE PATIENT WAS TESTED ON THE METER USING TEST STRIP LOT NUMBER 29778816, RESULTING WITH A VALUE OF 7.9 INR. AT AN UNKNOWN TIME, A SAMPLE FROM THE PATIENT WAS TESTED IN THE LABORATORY USING AN UNKNOWN METHOD, RESULTING AS 4.6 INR. AT A LATER UNKNOWN TIME, A SAMPLE FROM THE PATIENT WAS TESTED ON THE METER USING TEST STRIP LOT NUMBER 29778816, RESULTING WITH A VALUE OF > 8 INR. AT AN UNKNOWN TIME, A SAMPLE FROM THE PATIENT WAS TESTED ON THE METER USING TEST STRIP LOT NUMBER 244033, RESULTING AS 6.6 INR. NO ADVERSE EVENTS WERE ALLEGED TO HAVE OCCURRED WITH THE PATIENT. THE PATIENT'S PRODUCT WAS REQUESTED FOR INVESTIGATION. RELEVANT RETENTION TEST STRIPS (LOT 297788) WERE TESTED IN COMPARISON WITH THE MASTER LOT. FOR THIS PURPOSE TWO HUMAN BLOOD SAMPLES FROM MARCUMAR DONORS AND TWO INTERNAL REFERENCE METERS WERE USED. RETENTION SAMPLES WERE ACCEPTABLE. NO ERROR MESSAGES OCCURRED. EXTENSIVE MEASUREMENTS HAVE SHOWN HIGHER DEVIATIONS FOR COAGUCHEK VALUES > 4.5 INR COMPARED TO A LABORATORY METHOD. THEREFORE, THE CUSTOMER ALLEGATION HAS BEEN SUBSTANTIATED. A PRODUCT PROBLEM HAS BEEN FOUND FOR COAGUCHEK VALUES > 4.5 INR, WHICH WAS THE CASE IN THIS COMPLAINT. THIS CAN BE TRACED BACK TO THE CALIBRATION OF THE COMPLAINED TEST STRIPS TO THE WHO STANDARD RTF/16. FOR MEASUREMENTS > 4.5 INR. THE CUSTOMER IS ADVISED TO CONTACT THE PHYSICIAN AND PERFORM A MEASUREMENT WITH A LABORATORY METHOD. ROCHE DIAGNOSTICS HAS ISSUED A RECALL FOR THIS ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
853361 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME MONITOR GJS ROCHE DIAGNOSTICS NA 29778816

Patients

Seq Age Sex Outcome Treatment
1